<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05063032</url>
  </required_header>
  <id_info>
    <org_study_id>5825 v 3.0, 3030th March 2021</org_study_id>
    <nct_id>NCT05063032</nct_id>
  </id_info>
  <brief_title>Left Atrial FLUTter: a Comparison of Ablation Guided by High-density MApping and Empirical LINEar Ablation.</brief_title>
  <acronym>FLUTMALINE</acronym>
  <official_title>Left Atrial FLUTter: a Comparison of Ablation Guided by High-density MApping and Empirical LINEar Ablation - the FLUTMALINE Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitario La Paz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Universitario La Paz</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Unicenter, 1:1 randomized, open-labelled clinical trial comparing left atrial flutter&#xD;
      ablation using high density mapping or strict lineal ablation. Main outcome: arrhythmia&#xD;
      recurrences over 1 year follow-up with daily 1-lead 30 seconds ECG samples.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 31, 2021</start_date>
  <completion_date type="Anticipated">October 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>1:1 parallell, randomized, controlled, open-label, single center clinical trial.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of patients without sustained (≥30 s) atrial arrhythmia episodes over 1-year follow-up in each group.</measure>
    <time_frame>1 year follow-up</time_frame>
    <description>Daily 1-lead 30 seconds ECG samples.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Acute success.</measure>
    <time_frame>Acute intraprocedural.</time_frame>
    <description>Termination of all organized atrial arrhythmias (spontaneous or induced, organized and stable atrial arrhythmias with duration ≥3 min).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non-inducibility.</measure>
    <time_frame>Acute intraprocedural.</time_frame>
    <description>Non-inducibility of all organized atrial arrhythmias at the end of the ablation procedure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedure duration.</measure>
    <time_frame>Acute intraprocedural.</time_frame>
    <description>From vein puncture up to seaths withdrawal.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Left atrial dwell time.</measure>
    <time_frame>Acute intraprocedural.</time_frame>
    <description>From transeptal puncture up to catheters withdrawal from the left atrium.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety.</measure>
    <time_frame>Acute a 1 month after ablation (procedure-related complications).</time_frame>
    <description>Incidence of compications: 1)vascular lesions, 2)cardiac tamponade, 3)embolism.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospitalization.</measure>
    <time_frame>1 year.</time_frame>
    <description>Number of hospitalizations due to atrial arrhythmia episodes at 1-year follow-up.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Arrhythmias, Cardiac</condition>
  <arm_group>
    <arm_group_label>High-density mapping guided ablation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High-density map and return-cycles map in order to localize the protected isthmus with precision for focal/minimal ablation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Empirical linear ablation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Empirical predefined set of linear ablation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Radiofrecuency ablation</intervention_name>
    <description>Radiofrequency ablation to treat left atrial flutter, guided by high-density mapping versus linear ablation.</description>
    <arm_group_label>Empirical linear ablation</arm_group_label>
    <arm_group_label>High-density mapping guided ablation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria&#xD;
&#xD;
          -  Left atrial flutter1 inducible during electrophysiological evaluation.&#xD;
&#xD;
          -  Clinical indication for ablation: a) symptoms (palpitations, dizziness, syncope,&#xD;
             breathlessness, derangement, heart failure), tachymiopathy, b) poor heart rate&#xD;
             control, or c) recurrence after electrical cardioversion or failure of one&#xD;
             antiarrhythmic drug.&#xD;
&#xD;
          -  Informed consent.&#xD;
&#xD;
               1. Patients will be enrolled if LAFL is clinically suspected but finally randomized&#xD;
                  if this mechanism is established by electrophysiologic evaluation according to&#xD;
                  the criteria stated above.&#xD;
&#xD;
        Exclusion criteria&#xD;
&#xD;
          -  Previous ablation of LAFL.&#xD;
&#xD;
          -  Previous linear ablation in the LA except for pulmonary vein isolation.&#xD;
&#xD;
          -  Absolute contraindication for oral anticoagulation.&#xD;
&#xD;
          -  Stroke or acute coronary syndrome less than 3 months before ablation.&#xD;
&#xD;
          -  Complex congenital heart disease.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sergio C Castrejón, PhD</last_name>
    <phone>+34 659048245</phone>
    <email>lapaz@arritmias.net</email>
  </overall_contact>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 7, 2021</study_first_submitted>
  <study_first_submitted_qc>September 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 30, 2021</study_first_posted>
  <last_update_submitted>September 22, 2021</last_update_submitted>
  <last_update_submitted_qc>September 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Universitario La Paz</investigator_affiliation>
    <investigator_full_name>Dr. Sergio Castrejón-Castrejón</investigator_full_name>
    <investigator_title>Electrophysiologist, Principal investigator (togheter with Dr. José Luis Merino)</investigator_title>
  </responsible_party>
  <keyword>Left atrial flutter</keyword>
  <keyword>Linear ablation</keyword>
  <keyword>High-density mapping</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
    <mesh_term>Atrial Flutter</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

